Terms ending in 2038
Janssen Research & Development, LLC
Every in-force patent on Janssen Research & Development, LLC's record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,077,106 | Cancer Treatment In force · High confidence | Janssen Pharmaceutica N.V. | In force | High confidence | |
| US 12,006,302 | Tau Pet Imaging Ligands In force · High confidence | Janssen Pharmaceutica N.V. | In force | High confidence | |
| US 10,995,149 | Antibodies That Specifically Bind PD-1 and Methods of Use In force · High confidence | Janssen Biotech, Inc. | In force | High confidence | |
| US 11,786,665 | Grip Accessory for a Manual Injection Device In force · High confidence | Janssen Pharmaceuticals, Inc. | In force | High confidence | |
| US 11,918,791 | Grip Accessory for a Manual Injection Device In force · High confidence | Janssen Pharmaceuticals, Inc. | In force | High confidence | |
| US 11,059,850 | Novel Spirobicyclic Analogues In force · High confidence | Janssen Pharmaceutica N.V. | In force | High confidence | |
| US D1,007,675 | Pharmaceutical Ingredient Mixing Training Device In force · High confidence | Janssen Pharmaceutica N.V. | In force | High confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by Janssen Research & Development, LLC.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.